JSM 2004 - Toronto

JSM Activity #264

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
264 Applied Session Theme Session Tue, 8/10/04, 2:00 PM - 3:50 PM TCC-714 B
Design and Analysis Issues for Cancer Studies - Topic Contributed - Papers
Biometrics Section, Biopharmaceutical Section
Organizer(s): Terry Hyslop, Thomas Jefferson University
Chair(s): Terry Hyslop, Thomas Jefferson University
     2:05 PM   An Improved Design for Clinical Trials Evaluating Multiple Agents — Christine E. McLaren, University of California, Irvine; Vernon M. Chinchilli, Pennsylvania State University; Jennifer J. Roan, Minitab Inc.; Wen-Pin Chen, Chao Family Comprehensive Cancer Center; Frank L. Meyskens, Chao Family Comprehensive Cancer Center
     2:25 PM   The Use of Mediation Models to Identify and Validate Biomarkers — John Kittelson, University of Colorado Health Sciences Center; Patrick Blatchford, University of Colorado Health Sciences Center
     2:45 PM   Estimation of Binary Response with Order Restrictions — Jeremy M.G. Taylor, University of Michigan; Lu Wang, University of Michigan
     3:05 PM   Statistical Considerations in the Development and Validation of Prognostic Profiles Derived from Gene Expression Microarray Data — Lisa McShane, National Cancer Institute; Lara Lusa, Istituto Nazionale Tumori of Milan; Michael Radmacher, Kenyon College; Joanna H. Shih, National Cancer Institute; George Wright, National Cancer Institute; Richard Simon, National Institutes of Health
     3:25 PM   Clinical Trial Designs for Dose-seeking, Non-MTD Trials with Biomarker Endpoints — Sumithra J. Mandrekar, Mayo Clinic; ; Susan M. Geyer, Mayo Clinic; Vera Suman, Mayo Clinic; Karla Ballman, Mayo Clinic; Antje Hoering, Mayo Clinic; Daniel Sargent, Mayo Clinic
     3:45 PM   Floor Discussion
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004